Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 07 2019
Historique:
received: 02 01 2019
revised: 12 03 2019
accepted: 14 03 2019
pubmed: 18 5 2019
medline: 21 1 2020
entrez: 18 5 2019
Statut: ppublish

Résumé

While prescribed and illicit opioid use are primary drivers of the national surges in overdose deaths, opioid overdose deaths in which stimulants are also present are increasing in the U.S. We determined the social determinants and sociodemographic factors associated with opioid-only versus polysubstance opioid overdose deaths in Massachusetts. Particular attention was focused on the role of stimulants in opioid overdose deaths. We analyzed all opioid-related overdose deaths from 2014 to 2015 in an individually-linked population database in Massachusetts. We used linked postmortem toxicology data to identify drugs present at the time of death. We constructed a multinomial logistic regression model to identify factors associated with three mutually exclusive overdose death groups based on toxicological results: opioid-related deaths with (1) opioids only present, (2) opioids and other substances not including stimulants, and (3) opioids and stimulants with or without other substances. Between 2014 and 2015, there were 2,244 opioid-related overdose deaths in Massachusetts that had accompanying toxicology results. Toxicology reports indicated that 17% had opioids only, 36% had opioids plus stimulants, and 46% had opioids plus another non-stimulant substance. Persons older than 24 years, non-rural residents, those with comorbid mental illness, non-Hispanic black residents, and persons with recent homelessness were more likely than their counterparts to die with opioids and stimulants than opioids alone. Polysubstance opioid overdose is increasingly common in the US. Addressing modifiable social determinants of health, including barriers to mental health services and homelessness, is important to reduce polysubstance use and overdose deaths.

Sections du résumé

BACKGROUND AND AIMS
While prescribed and illicit opioid use are primary drivers of the national surges in overdose deaths, opioid overdose deaths in which stimulants are also present are increasing in the U.S. We determined the social determinants and sociodemographic factors associated with opioid-only versus polysubstance opioid overdose deaths in Massachusetts. Particular attention was focused on the role of stimulants in opioid overdose deaths.
METHODS
We analyzed all opioid-related overdose deaths from 2014 to 2015 in an individually-linked population database in Massachusetts. We used linked postmortem toxicology data to identify drugs present at the time of death. We constructed a multinomial logistic regression model to identify factors associated with three mutually exclusive overdose death groups based on toxicological results: opioid-related deaths with (1) opioids only present, (2) opioids and other substances not including stimulants, and (3) opioids and stimulants with or without other substances.
RESULTS
Between 2014 and 2015, there were 2,244 opioid-related overdose deaths in Massachusetts that had accompanying toxicology results. Toxicology reports indicated that 17% had opioids only, 36% had opioids plus stimulants, and 46% had opioids plus another non-stimulant substance. Persons older than 24 years, non-rural residents, those with comorbid mental illness, non-Hispanic black residents, and persons with recent homelessness were more likely than their counterparts to die with opioids and stimulants than opioids alone.
CONCLUSIONS
Polysubstance opioid overdose is increasingly common in the US. Addressing modifiable social determinants of health, including barriers to mental health services and homelessness, is important to reduce polysubstance use and overdose deaths.

Identifiants

pubmed: 31100636
pii: S0376-8716(19)30146-2
doi: 10.1016/j.drugalcdep.2019.03.014
pmc: PMC6588486
mid: NIHMS1031610
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Central Nervous System Stimulants 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-63

Subventions

Organisme : NIDA NIH HHS
ID : T32 DA013911
Pays : United States
Organisme : NIDA NIH HHS
ID : P30 DA040500
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM125507
Pays : United States
Organisme : NIDA NIH HHS
ID : K23 DA042168
Pays : United States
Organisme : NIDA NIH HHS
ID : R25 DA037190
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI042853
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

J Addict Dis. 2008;27(3):37-48
pubmed: 18956528
Am J Public Health. 2017 Mar;107(3):430-432
pubmed: 28177817
Drug Alcohol Depend. 2018 Apr 1;185:305-312
pubmed: 29486419
Addict Behav. 2017 May;68:39-44
pubmed: 28088742
Drug Alcohol Depend. 2017 Sep 1;178:501-511
pubmed: 28719884
MMWR Morb Mortal Wkly Rep. 2017 Feb 03;66(4):107-111
pubmed: 28151928
Drug Alcohol Depend. 2018 Jan 1;182:86-92
pubmed: 29175463
BMJ. 2017 Mar 14;356:j760
pubmed: 28292769
Ann Intern Med. 2018 Mar 20;168(6):453-455
pubmed: 29204603
MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-358
pubmed: 29596405
Subst Use Misuse. 2017 Jul 3;52(8):1051-1058
pubmed: 28323507
J Psychoactive Drugs. 2014 Apr-Jun;46(2):114-22
pubmed: 25052787
JAMA Netw Open. 2018 Jun 1;1(2):e180919
pubmed: 30646080
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427
pubmed: 30605448
N Engl J Med. 2018 Nov 1;379(18):1782
pubmed: 30380395
Drug Alcohol Depend. 2018 Sep 1;190:62-71
pubmed: 29981943
Drug Alcohol Depend. 2011 Jan 15;113(2-3):88-95
pubmed: 20828942
J Addict Dis. 2007;26(1):61-70
pubmed: 17439869

Auteurs

Joshua A Barocas (JA)

Division of Infectious Diseases, Boston Medical Center (BMC), 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA; Boston University School of Medicine, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA. Electronic address: Joshua.Barocas@BMC.org.

Jianing Wang (J)

Division of Infectious Diseases, Boston Medical Center (BMC), 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA; Boston University School of Medicine, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA.

Brandon D L Marshall (BDL)

Department of Epidemiology, Brown University School of Public Health, 121 South Main Street, Room 208 Box G-S121-2, Providence, RI 02912 USA.

Marc R LaRochelle (MR)

Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA.

Amy Bettano (A)

Massachusetts Department of Public Health, 250 Washington Street, 6th Floor, Boston, MA 02108, USA.

Dana Bernson (D)

Massachusetts Department of Public Health, 250 Washington Street, 6th Floor, Boston, MA 02108, USA.

Curt G Beckwith (CG)

Division of Infectious Diseases, Alpert Medical School of Brown University and the Miriam Hospital, 1125 N Main St, Providence, RI 02906, USA.

Benjamin P Linas (BP)

Division of Infectious Diseases, Boston Medical Center (BMC), 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA; Boston University School of Medicine, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA.

Alexander Y Walley (AY)

Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH